WithdrawnNot applicableNCT02700087
In Infants With Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms?
Studying Congenital laryngomalacia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Stanford University
- Principal Investigator
- Douglas R Sidell, MDStanford University
- Intervention
- ranitidine or famotidine(drug)
- Eligibility
- All sexes
- Timeline
- 2016 – 2017
Study locations (1)
- Lucile Packard Children's Hospital Stanford, Palo Alto, California, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02700087 on ClinicalTrials.gov